Optimization Study On Downstream Purification Process Of Chicken Embryo Harvest Liquid For Type IV Influenza Virus (Part 1)

Sep 16, 2026|

Influenza (also known as the flu) is a highly contagious respiratory infectious disease that can cause a variety of respiratory illnesses. According to authoritative data from the World Health Organization (WHO), approximately one billion people are threatened by influenza viruses each year. Influenza viruses (IVs) belong to the Orthomyxoviridae family and are single-stranded negative-sense RNA viruses. Influenza virus particles are spherical, with a diameter of 80-120 nm, and their structure can be divided into three layers from the outside in: an envelope, matrix proteins, and a core.

news-435-303

 

Structure of influenza A and B viruses

Antiviral drugs and direct vaccination against influenza are crucial steps in the current treatment and prevention of influenza. Currently, chicken embryo matrix and cell matrix are commonly used methods in influenza vaccine research , with chicken embryos being the most frequently chosen choice for preparing influenza virus fluid by researchers both domestically and internationally. Chicken embryo allantoic virus fluid contains numerous impurities, such as ovalbumin and viral structural proteins. Ovalbumin is a significant component that can cause allergic reactions in vaccine-immunized individuals. Therefore, the clarification, concentration, and purification of chicken embryo allantoic virus fluid are essential steps in the development of influenza virus vaccines.

Currently, the commonly used virus harvest fluid clarification technology is centrifugation + deep filtration . The main methods for purifying influenza virus include ultrafiltration, ultracentrifugation, gel filtration chromatography, and combined chromatography.

This study aims to investigate the infection characteristics of four influenza viruses-H1N1, H3N2, BV, and BY-in 9-11 day old chicken embryos. Monovalent viral allantoic fluid was obtained through chicken embryo culture to provide a basic material for subsequent downstream viral processing. During the study, different clarification, concentration, and purification methods were compared to optimize the separation of the target protein from other components (such as miscellaneous proteins and ovalbumin).

news-612-234


Experimental technology roadmap

Chicken embryos were cultured at 37℃ for 9-11 days . They were then inoculated with influenza A virus (A1 for H1N1, A3 for H3N2) at a MOI of 1:10000, and influenza B virus (B1 for BV, B2 for BY) at a MOI of 1:10000. H1N1 and H3N2 viruses were cultured at 33-34 ℃ for 48 hours, while BV and BY viruses were cultured at 33℃ for 7.2 hours . The embryos were then chilled, and the allantoic fluid was harvested. The allantoic fluid had a high total protein content, high viscosity, and appeared turbid, making clarification difficult.

Effects of different clarification processes on the quality of influenza virus harvest fluid of type IV

Clarification is an essential step in the purification process, serving as a preliminary pretreatment for a large number of insoluble impurities. This step uses allantoic fluid as raw material. After continuous flow high-speed centrifugation, the fluid is clarified and filtered through filter cartridges with pore sizes of 3μm and 0.8+0.45μm and 3μm and 0.8+0.65μm. The effects of the two filter cartridge sizes on the clarification process and results are investigated, and a suitable clarification scheme is selected to determine the optimal clarification process.

The results of the four types of influenza virus clarification fluid tests are shown in Figures 1-3 . CA1-1 represents the results of the clarification fluid tested using 3μm and 0.8+0.65μm filter cartridges, CA1-2 represents the results of the clarification fluid tested using 3μm and 0.8+0.45μm filter cartridges, and the rest are similar.

news-251-168


Figure 1. Detection results of influenza virus clarified solution - total protein content

news-251-195


Figure 2. Detection results of influenza virus clarified solution - hemagglutination titer

news-251-202


Figure 3. Detection results of influenza virus clarified solution - total protein removal rate

The results showed that although there were numerical differences in total protein content and total protein removal rate among the groups, there were no significant differences. This may be because the pore sizes of the filter cartridges were too small, and all could meet the clarification requirements. Regarding the blood coagulation titer, the 3μm and 0.8+0.45μm filter cartridges showed higher blood coagulation titers. Therefore, the smaller pore sizes of the 3μm and 0.8+0.45μm filter cartridges were selected for optimal clarification .

References: Huang, Zhentian. Optimization of downstream production process for quadrivalent influenza virus split vaccine [D]. Shenyang Agricultural University, 2024. DOI:10.27327/d.cnki.gshnu.2024.001595.

Send Inquiry